Inhaled nitric oxide improves lung allograft function after prolonged storage.

[1]  J. Cooper,et al.  Inhaled nitric oxide reduces human lung allograft dysfunction. , 1996, The Journal of thoracic and cardiovascular surgery.

[2]  O. H. Lowry,et al.  Administration of prostaglandin E1 after lung transplantation improves early graft function. , 1994, The Annals of thoracic surgery.

[3]  P. Dartevelle,et al.  Lung preservation with euro-collins, University of Wisconsin, wallwork, and low-potassium-dextran solutions , 1994 .

[4]  G. Patterson,et al.  Pentoxifylline reduces lung allograft reperfusion injury. , 1994, The Annals of thoracic surgery.

[5]  B. Kavanagh,et al.  Effects of inhaled NO and inhibition of endogenous NO synthesis in oxidant-induced acute lung injury. , 1994, Journal of applied physiology.

[6]  Arthur S Slutsky,et al.  Amelioration of post-ischemic lung reperfusion injury by prostaglandin E1. , 1993, The American review of respiratory disease.

[7]  P. Kubes,et al.  Nitric oxide prevents leukocyte adherence: role of superoxide. , 1993, The American journal of physiology.

[8]  P. Kubes,et al.  Inhibition of nitric oxide production. Mechanisms of vascular albumin leakage. , 1993, Circulation research.

[9]  J. R. Lancaster,et al.  Nitric oxide--a new endogenous immunomodulator. , 1993, Transplantation.

[10]  R. Strieter,et al.  The bimodal expression of tumor necrosis factor-alpha in association with rat lung reimplantation and allograft rejection. , 1993, Journal of immunology.

[11]  R. Rossaint,et al.  Inhaled nitric oxide for the adult respiratory distress syndrome. , 1993, The New England journal of medicine.

[12]  C. N. Gillis,et al.  Pulmonary vasodilation by inhaled nitric oxide after endothelial injury. , 1992, Journal of applied physiology.

[13]  J. Warren,et al.  Inhibition in the rat of nitric oxide synthesis in vivo does not attenuate the hypotensive action of acetylcholine, ATP or bradykinin , 1992, Experimental physiology.

[14]  P. Kubes,et al.  Nitric oxide modulates microvascular permeability. , 1992, The American journal of physiology.

[15]  W. Jamieson,et al.  Effects of platelet-activating factor antagonist CV-3988 in preservation of heart and lung for transplantation. , 1991, The Annals of thoracic surgery.

[16]  S. Moncada,et al.  Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.

[17]  P. Kubes,et al.  Nitric oxide: an endogenous modulator of leukocyte adhesion. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J. Wain,et al.  Inhaled Nitric Oxide: A Selective Pulmonary Vasodilator Reversing Hypoxic Pulmonary Vasoconstriction , 1991, Circulation.

[19]  L. Ignarro,et al.  Biological Actions and Properties of Endothelium-Derived Nitric Oxide Formed and Released From Artery and Vein , 1989, Circulation research.

[20]  J. Vane,et al.  Endothelium-derived relaxing factor reduces platelet adhesion to bovine endothelial cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[21]  S. Moncada,et al.  ENDOGENOUS NITRIC OXIDE INHIBITS HUMAN PLATELET ADHESION TO VASCULAR ENDOTHELIUM , 1987, The Lancet.

[22]  S. Moncada,et al.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.

[23]  W. Baumgartner,et al.  Twenty-four hour lung preservation by hypothermia and leukocyte depletion. , 1985, The Journal of heart transplantation.

[24]  J. McCord,et al.  Oxygen-derived free radicals in postischemic tissue injury. , 1985, The New England journal of medicine.

[25]  W. Stenson,et al.  Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity: Assessment of inflammation in rat and hamster models , 1984 .

[26]  J. Hardy,et al.  Surgical technique of one-stage bilateral lung reimplantation in the dog. , 1971, The Journal of thoracic and cardiovascular surgery.

[27]  D. Lefer,et al.  Endothelial and Myocardial Cell Protection by a Cysteine‐Containing Nitric Oxide Donor After Myocardial Ischemia and Reperfusion , 1993, Journal of cardiovascular pharmacology.